Recombinant multi-species IKK Alpha/IKKA/CHUK protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis

Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine IKK Alpha/IKKA/CHUK protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
This gene encodes a member of the serine/threonine protein kinase family. The encoded protein, a component of a cytokine-activated protein complex that is an inhibitor of the essential transcription factor NF-kappa-B complex, phosphorylates sites that trigger the degradation of the inhibitor via the ubiquination pathway, thereby activating the transcription factor. [provided by RefSeq, Jul 2008]
The Alternative Names of target: BPS2,CHUK,Chuk,Chuk1,Conserved helix-loop-helix ubiquitous kinase,Fbx24,Fbxo24,I-kappa-B kinase 1 (IKK-1,I-kappa-B kinase alpha,IKBKA,IKK Alpha,IKK alpha,IKK-1,IKK-A,IKK-alpha,IKK1,IKK1),IKKA,IKKalpha,IkBKA,IkappaB kinase,Ikbka,Ikka,Inhibitor of nuclear factor kappa-B kinase subunit alpha,NFKBIKA,Nuclear factor NF-kappa-B inhibitor kinase alpha (NFKBIKA),TCF16,Transcription factor 16 (TCF-16)

Target products collectionGo to IKK Alpha/IKKA/CHUK products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdfMSDSpdfCOApdfDatasheet

Product information

Catalog No. Product Name Species Reactivity
GM-Tg-hg-T65879-Ag-1/ GM-Tg-hg-T65879-Ag-2 Human IKK Alpha/IKKA/CHUK protein Human
GM-Tg-rg-T65879-Ag-1/ GM-Tg-rg-T65879-Ag-2 Rat IKK Alpha/IKKA/CHUK protein Rat
GM-Tg-mg-T65879-Ag-1/ GM-Tg-mg-T65879-Ag-2 Mouse IKK Alpha/IKKA/CHUK protein Mouse
GM-Tg-cynog-T65879-Ag-1/ GM-Tg-cynog-T65879-Ag-2 Cynomolgus/Rhesus macaque IKK Alpha/IKKA/CHUK protein Cynomolgus/ Rhesus macaque
GM-Tg-felg-T65879-Ag-1/ GM-Tg-felg-T65879-Ag-2 Feline IKK Alpha/IKKA/CHUK protein Feline
GM-Tg-cang-T65879-Ag-1/ GM-Tg-cang-T65879-Ag-2 Canine IKK Alpha/IKKA/CHUK protein Canine
GM-Tg-bovg-T65879-Ag-1/ GM-Tg-bovg-T65879-Ag-2 Bovine IKK Alpha/IKKA/CHUK protein Bovine
GM-Tg-equg-T65879-Ag-1/ GM-Tg-equg-T65879-Ag-2 Equine IKK Alpha/IKKA/CHUK protein Equine

Size： 1mg | 10mg | 100mg



Product Description

Catalog No. GM-Tg-hg-T65879-Ag-1/ GM-Tg-hg-T65879-Ag-2; GM-Tg-rg-T65879-Ag-1/ GM-Tg-rg-T65879-Ag-2;
GM-Tg-mg-T65879-Ag-1/ GM-Tg-mg-T65879-Ag-2; GM-Tg-cynog-T65879-Ag-1/ GM-Tg-cynog-T65879-Ag-2;
GM-Tg-felg-T65879-Ag-1/ GM-Tg-felg-T65879-Ag-2; GM-Tg-cang-T65879-Ag-1/ GM-Tg-cang-T65879-Ag-2;
GM-Tg-bovg-T65879-Ag-1/ GM-Tg-bovg-T65879-Ag-2; GM-Tg-equg-T65879-Ag-1/ GM-Tg-equg-T65879-Ag-2
Products Name IKK Alpha/IKKA/CHUK protein
Species Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine
Target Name IKK Alpha/IKKA/CHUK
Protein Sub-location Introcelluar Protein
Isotypes Recombinant protein
Expression platform Mammalian cell
Bioactivity validation Affintiy&bioactivity validated by ELISA, cell culture validated.
Tag His
Products description Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine IKK Alpha/IKKA/CHUK protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic).
Purity Purity: ≥95% (SDS-PAGE)
Application In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference






    About Gmab

    GDU
    GDU

    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.